Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(25 sites)
United States
Phoenix Children's Hospital, Phoenix, Arizona Arkansas Children's Hospital, Little Rock, Arkansas Children's Hospital Los Angeles, Los Angeles, California Valley Children's Hospital, Madera, California Children's Hospital of Orange County, Orange, California Stanford University, Palo Alto, California Rady Children's Hospital San Diego, San Diego, California Arnold Palmer Hospital for Children, Orlando, Florida Children's Hospital of Minnesota, Minneapolis, Minnesota Memorial Sloan Kettering Cancer Center, New York, New York Novant Health - Hemby Children's Hospital, Charlotte, North Carolina Doernbecher Children's Hospital, Portland, Oregon Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania MD Anderson, Houston, Texas University of Texas Health Science Center San Antonio, San Antonio, Texas University of Utah Huntsman Cancer Institute, Salt Lake City, Utah Children's Hospital of The King's Daughters, Norfolk, Virginia University of Wisconsin Carbone Cancer Center, Madison, Wisconsin Canada
Alberta Children's Hospital, Calgary, Alberta Stollery Children's Hospital, Edmonton, Alberta BC Children's Hospital, Vancouver, British Columbia McMaster Children's Hospital, Hamilton, Ontario CHU Sainte-Justine, Montreal, Quebec Montreal Children's Hospital, Montreal, Quebec Chu De Quebec, Québec, Quebec